7V5N | pdb_00007v5n

Crystal structure of Fab fragment of bevacizumab bound to DNA aptamer


Domain Annotation: ECOD Classification ECOD Database Homepage

ChainsFamily NameDomain Identifier ArchitecturePossible HomologyHomologyTopologyFamilyProvenance Source (Version)
E [auth F]e7v5nF1 A: Family A G protein-coupled receptor-likeX: Family A G protein-coupled receptor-likeH: Family A G protein-coupled receptor-likeT: LysR_substrateF:ECOD (20:10:01)
Be7v5nB1 A: Family A G protein-coupled receptor-likeX: Family A G protein-coupled receptor-likeH: Family A G protein-coupled receptor-likeT: Fer4+Fer4_7F:ECOD (20:10:01)
D [auth E]e7v5nE1 A: Family A G protein-coupled receptor-likeX: Family A G protein-coupled receptor-likeH: Family A G protein-coupled receptor-likeT: LysR_substrateF:ECOD (20:10:01)
Ae7v5nA1 A: Family A G protein-coupled receptor-likeX: Family A G protein-coupled receptor-likeH: Family A G protein-coupled receptor-likeT: Fer4+Fer4_7F:ECOD (20:10:01)

Domain Annotation: CATH CATH Database Homepage

ChainDomainClassArchitectureTopologyHomologyProvenance Source (Version)
E [auth F]2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (utative)
B2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (utative)
D [auth E]2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (utative)
A2.60.40.10 Mainly Beta Sandwich Immunoglobulin-like ImmunoglobulinsCATH (utative)

SAbDab Antibody Annotation SAbDab Database Homepage

ChainChain ClassChain SubclassChain TypeAntigen Name(s) Provenance Source
B,
E [auth F]
Heavy ChainIGHV3 -dna (5'-d(*gp*cp*gp*gp*tp*tp*gp*gp*tp*gp*gp*tp*ap*gp*tp*tp*ap*cp*gp*tp*tp*cp* gp*c)-3') SAbDab (2026-03-13)
A,
D [auth E]
Light ChainIGKV1 Kappadna (5'-d(*gp*cp*gp*gp*tp*tp*gp*gp*tp*gp*gp*tp*ap*gp*tp*tp*ap*cp*gp*tp*tp*cp* gp*c)-3') SAbDab (2026-03-13)

Thera-SAbDab Antibody Annotation Thera-SAbDab Database Homepage

ChainNameTargetProvenance Source
B,
E [auth F]
Ranibizumab VEGFA, PDCD1/CD279/PD1, ANGPT2Therapeutic SAbDab (2026-03-13)
A,
D [auth E]
Bevacizumab VEGFA, ANGPT2, PDCD1/CD279/PD1Therapeutic SAbDab (2026-03-13)